Facet Life Sciences Appoints Tobias Massa, PhD to Board of Directors

Share Article

Seasoned Life Sciences Expert Joins Innovative Development Solution Provider

Tobias Massa Facet Life Sciences Board of Directors

Tobias Massa, Ph.D. Joins Facet Life Sciences Board of Directors

In the life sciences industry, so many novel products are being produced by very small development teams. This is the segment of the market where science and innovation are flourishing. I am excited to work with the Facet Life Sciences team!

Facet Life Sciences, a leading provider of development solutions (software and services) for small and growing life sciences teams, today announced that Tobias Massa, PhD has joined the company’s Board of Directors.

Dr. Massa brings 38 years of success in pharmaceuticals, biotech, life sciences, and technology to his Board position. Most recently he served as VP and Head of Global Regulatory Operations at Sanofi. During his tenure, he spearheaded multiple organizational change projects including the creation of an outsourcing program for non-strategic regulatory activity; strategic planning for the establishment of a regulatory outsourcing center; the consolidation of regulatory processes and tools; and the development of a foundation for the transition of traditional services to a multi-tenant cloud-based SaaS system. Prior to Sanofi, Dr. Massa spent ten years at Bristol-Myers Squibb where he led Global Regulatory CMC/Operations/ Mature Product Strategy.

Ken VanLuvanee, President and CEO, Facet Life Sciences, commented, “Toby has an incredible career-spanning track record of innovation. He understands life sciences R&D but more importantly, he has practical, experience-based insight into how we can improve it. His pioneering attitude aligns well with our innovative technology and service strategy designed for small teams. We look forward to his contributions as a member of the Facet Board of Directors.”

Dr. Massa added, “In the life sciences industry, so many novel products are being produced by very small development teams. This is the segment of the market where science and innovation are flourishing. I am excited to work with the Facet Life Sciences team because they are so dedicated to this under-served group.”

The Facet Life Sciences Board of Directors also includes Ken VanLuvanee, President and CEO and Lisa Jenkins VanLuvanee, Vice President, Research and Development.

About Facet Life Sciences
Facet Life Sciences is the leading provider of innovative development solutions (software and services) designed to help small teams get their INDs to and through the FDA. Our research and development specialists deliver expert services and cutting-edge technologies that speed product R&D efforts. Facet teams create and manage critical development documentation for some of the industry’s fastest growing life sciences companies.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Monique Garrett
Visit website